ARS Pharmaceuticals Inc — Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

Haberler

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

China approves first community use epinephrine nasal spray for allergies

ARS Pharma CBO Chakma 1,47 milyon dolar değerinde hisse sattı

Dorsey, ARS Pharma COO’su, 190 bin dolarlık SPRY hissesi sattı

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

ARS Pharmaceuticals hisseleri güçlü 3. çeyrek satışlarıyla yükseldi, Raymond James Güçlü Al tavsiyesini yineledi

William Blair, neffy verileri sonrası ARS Pharmaceuticals hissesi için Outperform notunu yineledi

ARS Pharmaceuticals stock reaffirmed Outperform by William Blair on neffy data